Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-02 | 2021-02-23 | 123581 |
APO-VARENICLINE | 1MG | TABLET | Resolved | 2020-09-02 | 2020-09-14 | 123586 |
APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2020-09-02 | 2020-09-14 | 123589 |
APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2020-09-09 | 2020-09-28 | 123892 |
APO-BISOPROLOL | 5MG | TABLET | Resolved | 2020-09-09 | 2020-10-05 | 123914 |
APO-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2020-09-09 | 2020-10-26 | 123921 |
APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-09-09 | 2020-11-02 | 123927 |
APO-ENALAPRIL | 5MG | TABLET | Resolved | 2020-09-09 | 2021-03-09 | 123932 |
APO-LEVOCARB-TAB 25MG/100MG | 25MG 100MG | TABLET | Resolved | 2020-09-09 | 2020-09-21 | 123939 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2020-09-09 | 2020-12-07 | 123944 |
APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-09-09 | 2020-12-07 | 123951 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2020-09-09 | 2020-10-05 | 123954 |
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2020-09-09 | 2020-12-17 | 123957 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-17 | 2020-10-08 | 124344 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2020-09-17 | 2020-09-25 | 124347 |
APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Resolved | 2020-09-17 | 2020-10-05 | 124350 |
APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-09-17 | 2020-09-28 | 124353 |
APO-PROPAFENONE | 150MG | TABLET | Resolved | 2020-09-17 | 2020-10-05 | 124356 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-17 | 2021-02-23 | 124359 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-09-22 | 2020-12-30 | 124783 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |